Cargando…
Somatic alterations of the SMAD-2 gene in human colorectal cancers.
The SMAD-2 gene, which is located at 18q21, has been identified as a candidate tumour-suppressor gene from work on colorectal cancers. The aim of the present study was to determine the clinical alterations and the significance of its mutations in a series of colorectal cancers previously examined fo...
Autores principales: | Takagi, Y., Koumura, H., Futamura, M., Aoki, S., Ymaguchi, K., Kida, H., Tanemura, H., Shimokawa, K., Saji, S. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group|1
1998
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2063002/ https://www.ncbi.nlm.nih.gov/pubmed/9820171 |
Ejemplares similares
-
Somatic SMAD3-activating mutations cause melorheostosis by up-regulating the TGF-β/SMAD pathway
por: Kang, Heeseog, et al.
Publicado: (2020) -
Hide and seek: Somatic SMAD3 mutations in melorheostosis
por: Velchev, Joe Davis, et al.
Publicado: (2020) -
Centrosomal Kinases, HsAIRK1 and HsAIRK3, are Overexpressed in Primary Colorectal Cancers
por: Takahashi, Takao, et al.
Publicado: (2000) -
Characterization of SMAD2 Activation in Human Thoracic Aortic Aneurysm
por: Fukuda, Hayato, et al.
Publicado: (2018) -
Pharmacokinetics of a Single Dose of Azilsartan in Pediatric Patients: A Phase 3, Open-Label, Multicenter Study
por: Enya, Kazuaki, et al.
Publicado: (2018)